Abstract
Introduction

49
With the increasing concerns over food safety, environment contamination, and general 50 health risks, the search for decreasing the high fat content of animal products is indeed needed.
51
Alfalfa is very effective in decreasing egg cholesterol with the least loss in egg production, 52 egg size, and feed efficiency (Menge et al., 1974; Shi et al., 2014) . Previous studies suggested 53 that alfalfa saponins might prevent hypercholesterolemia, reduce egg production, and 54 suppress growth in mammals and birds (Anderson, 1957 Whitehead et al., 1981) . Aqueous alfalfa extract also have been reported to alter the 57 lipid metabolism of chicken (Deng et al., 2012; Dong et al., 2007) .
58
Cholesterol metabolism in laying hens has been under investigation for several decades.
59
Cholesterol intake from a conventional laying diets could not meet the hens' needs, requiring 60 hens to synthesis most of the cholesterol needed for the egg, as structural components of cell 61 membranes, and as precursors to sex and adrenal hormones, vitamin D, and the bile acids 62 (Hargis, 1988) . Cells must balance the internal and external sources of cholesterol so as to 63 maintain mevalonate biosynthesis while at the same time avoiding the accumulation of 64 excessive cholesterol, which can result in diseases such as atherosclerosis, gallstones and 65 several lipid storage disorders (Goldstein and Brown, 1990) . It is well established that 66 cholesterol homeostasis is maintained in normal animals through two regulated pathways: de 67 novo synthesis and catabolism (Peet et al., 1998 (VLDL-C), were measured by automatic clinical chemistry analyzer (Hitachi, Tokyo, Japan).
114
After blood sampling, the birds were euthanized by cervical dislocation immediately.
115
The liver was dissected, weighted and then homogenized before freezing for storage at-20 ℃.
116
The ovarian tissue was also dissected and marked then freezing for storage at -80 ℃. The 
Statistical analysis
135
Data are presented as mean ± standard deviation (SD). The data were analyzed by 136 one-way ANOVA using SPSS 22 software (SPSS, Chicago, USA). The differences between 137 the means were determined using Duncan's test. Differences were considered significant at 138 the level of P < 0.05 and P < 0.01 were considered very significant differences. difference between ASE at 0 and 60 mg/kg (P < 0.05), while there was no significant 154 difference detected between ASE at 0 and 480 mg/kg (P > 0.05). Fig. 1D showed that there 155 were no significant differences on feed efficiency with ASE at 0, 60, 240 and 480 mg/kg (P > 156 0.05), but a significant difference existed for ASE at 0 and 120 mg/kg (P < 0.05).
157
As summarized in Fig. 2A -C, there were no significant differences on egg shape index, 
Cholesterol concentration and serum lipid indices
165
The effects of ASE on cholesterol and BA are presented in Fig. 3 . The yolk cholesterol
166
and liver bile acid decreased in all of the four ASE treatment groups compared to ASE 0 167 mg/kg group. Yolk cholesterol decreased significantly in ASE 60 and 480 mg/kg (P < 0.05).
168
Liver BA in ASE 60 and 240 mg/kg decreased significantly (P < 0.05 and P < 0.01 separately) 169 compared to ASE 0 mg/kg group. Liver cholesterol level elevated in ASE 60, 120 and 480 170 mg/kg groups, but ASE 240 group decreased. ASE 240 group showed significant difference 171 with ASE 0, 60 and 120 mg/kg groups (P < 0.05), while ASE 480 group had very significant 172 differences with either one of other four groups (P < 0.01). Although there were fluctuations 173 regarding to the fecal BA in ASE groups, there were no significant differences detected (P > 174 0.05).
175
As shown in Fig. 4 , there were no significant differences on the TC, TG, HDL-C, LDL-C
176
and VLDL-C levels with different ASE supplements (P > 0.05). 
Gene expression in the liver and ovary
178
The mRNA levels of gene apoVLDL-Ⅱ in the liver was significantly higher in the ASE 179 60 mg/kg group than the ASE 0 mg/kg group through supplemental ASE in the diet of laying 180 hens. However, the other treatments did not show significant change compared to the ASE 0 181 mg/kg group (Fig. 5A ).
182
The mRNA levels of VLDLR in ovary was significantly (P < 0.05) suppressed by 183 supplemental ASE in the diet (P < 0.05) (Fig. 5B) . While the expression of CYP7A1 (Fig. 5C) 
184
and HMG-CoA reductase (Fig. 5D ) genes in liver had the same trend, the treatment groups 
Discussion
189
In our study, dietary ASE had no significant effects on the performance of laying hens. extract had no significant effect on the production performance of laying hens.
193
Supplemented with ASE in the diet of laying hens in our experimental period, feed
194
intake declined compared to the control group. This might because the poor palatability of
195
ASE due to the bitterness of alfalfa saponin (Zhou et al., 2014) . This is in accordance with the 196 dietary saponin in laying hens (Sim et al., 1984) . Over the experimental period, ASE 
214
The cholesterol of serum mainly included body biosynthesis and intestinal absorption,
215
both of them maintained the relative balance. In this present study, ASE had no significant 216 effects on the serum lipid indices in laying hens. This might due to the balance of cholesterol 217 metabolism maintained by the body.
218
Cholesterol metabolism in all tissues of the body except the central nervous system is in triglyceride-rich lipoproteins (Griffin, 1992 
